A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...
A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction. Review: The role of ...
Katelyn Fullbright on the day she graduated from Women in Recovery.Credit...Barrett Emke for The New York Times Supported by By Nicholas Kristof Photographs by Barrett Emke Mr. Kristof is an Opinion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results